BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6314867)

  • 41. [Prolyl hydroxylase activity in liver specimens in chronic liver diseases (author's transl)].
    Langness U; Clausnitzer H; Verspohl M; Grasedyck K
    Med Klin; 1978 Aug; 73(34):1179-82. PubMed ID: 210365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical feminization and serum testosterone levels in male patients with chronic African endomyocardial fibrosis.
    Bolarin DM; Andy JJ
    Trop Geogr Med; 1982; 34(4):309-12. PubMed ID: 7167998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
    Niemelä O; Risteli L; Sotaniemi EA; Risteli J
    Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Progress in the diagnosis of chronic liver disease: diagnostic activity in liver fibrosis and cirrhosis].
    Pott G; Gerlach U
    Leber Magen Darm; 1982 Aug; 12(4):141-4. PubMed ID: 6752610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The relationship between the levels of serum fibrosis marks and morphometric quantitative measurement of hepatic histological fibrosis].
    Xie S; Yao J; Zheng S; Yao C; Zheng R
    Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):203-5. PubMed ID: 10951617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolyl hydroxylase activity in liver and serum of rats and human subjects intoxicated by chronic administration of ethanol.
    Pawlicka E; Bańkowski E; Pałka J; Markiewicz W
    Hepatogastroenterology; 1987 Dec; 34(6):243-5. PubMed ID: 2828207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
    Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Proline hydroxylase (hPH) as marker of hepatic fibrosis in beta thalassemia].
    Leonardi S; Avola E; Rapisarda R; La Delfa W; Musumeci S
    Pediatr Med Chir; 1991; 13(3):267-9. PubMed ID: 1658753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Liver fibrosis. 2].
    Hahn EG; Ott U; Martini GA
    Z Gastroenterol; 1980 Oct; 18(10):507-23. PubMed ID: 6109405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are serum type III procollagen and prolyl hydroxylase useful as noninvasive markers of liver disease in patients with cystic fibrosis?
    Leonardi S; Giambusso F; Sciuto C; Castiglione S; Castiglione N; La Rosa M
    J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):603-5. PubMed ID: 9822332
    [No Abstract]   [Full Text] [Related]  

  • 51. [What is reliable in therapy of liver fibrosis?].
    Högemann B
    Z Gastroenterol; 1992 May; 30(5):333-6. PubMed ID: 1321534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An immunohistochemical and serum ELISA study of type I and III procollagen aminopropeptides in primary biliary cirrhosis.
    Davis BH; Madri JA
    Am J Pathol; 1987 Aug; 128(2):265-75. PubMed ID: 3303951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracellular enzymes of collagen biosynthesis in human platelets.
    Anttinen H; Tuderman L; Oikarinen A; Kivirikko KI
    Blood; 1977 Jul; 50(1):29-37. PubMed ID: 194639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis.
    Murawaki Y; Ikuta Y; Nishimura Y; Koda M; Kawasaki H
    J Gastroenterol Hepatol; 1996 May; 11(5):443-50. PubMed ID: 8743916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical assessment of myocardial fibrosis in hypertensive heart disease.
    López B; González A; Varo N; Laviades C; Querejeta R; Díez J
    Hypertension; 2001 Nov; 38(5):1222-6. PubMed ID: 11711527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prolonged exercise causes an increase in the activity of galactosylhydroxylysyl glucosyltransferase and in the concentration of type III procollagen aminopropeptide in human serum.
    Takala TE; Vuori J; Anttinen H; Väänänen K; Myllylä R
    Pflugers Arch; 1986 Nov; 407(5):500-3. PubMed ID: 2947039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Assay of serum collagen markers in chronic liver diseases and liver cancer].
    Inoue T; Funaki N; Hatahara T; Igarashi S; Kaneko E; Tanaka H
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1506-13. PubMed ID: 2170716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Course of the prolyl hydroxylase activity and the quantity of collagen amino acids in the liver during a 2-year experimental chronic iron overload in baboons].
    Farjanel J; Périer C; Brissot P; Campion JP; Simon M; Ferrand B; Bourel M
    Gastroenterol Clin Biol; 1983 Jan; 7(1):75-80. PubMed ID: 6301921
    [No Abstract]   [Full Text] [Related]  

  • 59. Prolyl hydroxylase and procollagen III peptide levels in the sera from patients with collagen diseases and psoriasis.
    Sasaki T; Nakajima H
    J Dermatol; 1989 Jun; 16(3):207-11. PubMed ID: 2551942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Activity diagnosis of liver fibrosis and liver cirrhosis].
    Langness U
    Med Klin; 1977 Mar; 72(12):492-6. PubMed ID: 190524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.